학술논문

Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
Document Type
Article
Source
Clinical Trials; Feb2022, Vol. 19 Issue 1, p52-61, 10p
Subject
DRUG efficacy
SARS-CoV-2
COVID-19
CLINICAL trials
ANTIVIRAL agents
MEDICAL protocols
Language
ISSN
17407745
Abstract
Copyright of Clinical Trials is the property of Sage Publications, Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)